Literature DB >> 25176333

Stem cell-based therapies for cancer treatment: separating hope from hype.

Daniel W Stuckey1, Khalid Shah2.   

Abstract

Stem cell-based therapies are emerging as a promising strategy to tackle cancer. Multiple stem cell types have been shown to exhibit inherent tropism towards tumours. Moreover, when engineered to express therapeutic agents, these pathotropic delivery vehicles can effectively target sites of malignancy. This perspective considers the current status of stem cell-based treatments for cancer and provides a rationale for translating the most promising preclinical studies into the clinic.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25176333      PMCID: PMC4234304          DOI: 10.1038/nrc3798

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  125 in total

1.  Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.

Authors:  Mariam A Stoff-Khalili; Angel A Rivera; J Michael Mathis; N Sanjib Banerjee; Amanda S Moon; A Hess; Rodney P Rocconi; T Michael Numnum; M Everts; Louise T Chow; Joanne T Douglas; Gene P Siegal; Zeng B Zhu; Hans Georg Bender; Peter Dall; Alexander Stoff; Larissa Pereboeva; David T Curiel
Journal:  Breast Cancer Res Treat       Date:  2007-01-13       Impact factor: 4.872

2.  Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells.

Authors:  Lior Zangi; Raanan Margalit; Shlomit Reich-Zeliger; Esther Bachar-Lustig; Andreas Beilhack; Robert Negrin; Yair Reisner
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

Review 3.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

4.  A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells.

Authors:  Katharina Hansen; Franz-Josef Müller; Markus Messing; Frank Zeigler; Jeanne F Loring; Katrin Lamszus; Manfred Westphal; Nils Ole Schmidt
Journal:  Neuro Oncol       Date:  2010-02-14       Impact factor: 12.300

Review 5.  Hyaluronic acid hydrogels for biomedical applications.

Authors:  Jason A Burdick; Glenn D Prestwich
Journal:  Adv Mater       Date:  2011-03-10       Impact factor: 30.849

6.  HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival.

Authors:  S Harrow; V Papanastassiou; J Harland; R Mabbs; R Petty; M Fraser; D Hadley; J Patterson; S M Brown; R Rampling
Journal:  Gene Ther       Date:  2004-11       Impact factor: 5.250

7.  Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.

Authors:  Alice B Brown; Wendy Yang; Nils O Schmidt; Rona Carroll; Kim K Leishear; Nikolai G Rainov; Peter M Black; Xandra O Breakefield; Karen S Aboody
Journal:  Hum Gene Ther       Date:  2003-12-10       Impact factor: 5.695

8.  Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma.

Authors:  Cihui Yan; Shuangjing Li; Zhenzhen Li; Hongwei Peng; Xiangfei Yuan; Linlin Jiang; Yanjun Zhang; Dongmei Fan; Xiao Hu; Ming Yang; Dongsheng Xiong
Journal:  Mol Pharm       Date:  2012-12-07       Impact factor: 4.939

9.  Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats.

Authors:  Gang Xu; Xiao-Dan Jiang; Ying Xu; Jing Zhang; Fan-Heng Huang; Zhen-Zhou Chen; De-Xiang Zhou; Jiang-Hua Shang; Yu-Xi Zou; Ying-Qian Cai; Sheng-Bin Kou; Yi-Zhao Chen; Ru-Xiang Xu; Yan-Jun Zeng
Journal:  Cell Biol Int       Date:  2008-08-06       Impact factor: 3.612

10.  An effective approach to prevent immune rejection of human ESC-derived allografts.

Authors:  Zhili Rong; Meiyan Wang; Zheng Hu; Martin Stradner; Shengyun Zhu; Huijuan Kong; Huanfa Yi; Ananda Goldrath; Yong-Guang Yang; Yang Xu; Xuemei Fu
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

View more
  67 in total

Review 1.  Neural stem cell therapy for cancer.

Authors:  Juli Rodriguez Bagó; Kevin T Sheets; Shawn D Hingtgen
Journal:  Methods       Date:  2015-08-24       Impact factor: 3.608

2.  Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.

Authors:  Wanlu Du; Ivan Seah; Oumaima Bougazzoul; GiHun Choi; Katrina Meeth; Marcus W Bosenberg; Hiroaki Wakimoto; David Fisher; Khalid Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-14       Impact factor: 11.205

3.  Kinins in Glioblastoma Microenvironment.

Authors:  Mona N Oliveira; Barbara Breznik; Micheli M Pillat; Ricardo L Pereira; Henning Ulrich; Tamara T Lah
Journal:  Cancer Microenviron       Date:  2019-08-16

4.  Genetic engineering of platelets to neutralize circulating tumor cells.

Authors:  Jiahe Li; Charles C Sharkey; Brittany Wun; Jane L Liesveld; Michael R King
Journal:  J Control Release       Date:  2016-02-26       Impact factor: 9.776

5.  Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas.

Authors:  Sung Hugh Choi; Daniel W Stuckey; Sara Pignatta; Clemens Reinshagen; Jasneet Kaur Khalsa; Nicolaas Roozendaal; Jordi Martinez-Quintanilla; Kaoru Tamura; Erhan Keles; Khalid Shah
Journal:  Clin Cancer Res       Date:  2017-09-14       Impact factor: 12.531

6.  Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity.

Authors:  Pan Yin; Liming Gui; Caihong Wang; Jingjing Yan; Min Liu; Lu Ji; You Wang; Bin Ma; Wei-Qiang Gao
Journal:  Mol Ther       Date:  2020-08-08       Impact factor: 11.454

Review 7.  The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.

Authors:  Costas D Arvanitis; Gino B Ferraro; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2019-10-10       Impact factor: 60.716

Review 8.  The role of octamer binding transcription factors in glioblastoma multiforme.

Authors:  A K Rooj; A Bronisz; J Godlewski
Journal:  Biochim Biophys Acta       Date:  2016-03-08

9.  Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells.

Authors:  Tugba Bagci-Onder; Wanlu Du; Jose-Luiz Figueiredo; Jordi Martinez-Quintanilla; Khalid Shah
Journal:  Brain       Date:  2015-04-23       Impact factor: 13.501

10.  Stem Cells Engineered During Different Stages of Reprogramming Reveal Varying Therapeutic Efficacies.

Authors:  Deepak Bhere; Rajiv Kumar Khajuria; William T Hendriks; Antara Bandyopadhyay; Tugba Bagci-Onder; Khalid Shah
Journal:  Stem Cells       Date:  2018-04-01       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.